Quality of life and health economic assessments of age-related macular degeneration

Surv Ophthalmol. 2007 Jan;52 Suppl 1:S20-5. doi: 10.1016/j.survophthal.2006.10.014.

Abstract

In this article, we review measures of patient-reported outcomes that can show whether a treatment for age-related macular degeneration also provides patient-perceived benefits. In addition, we look at health economic measurements currently being used to develop cost-effectiveness models for age-related macular degeneration.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Blindness / economics
  • Cost of Illness*
  • Cost-Benefit Analysis
  • Delivery of Health Care / economics*
  • Humans
  • Macular Degeneration / economics*
  • Quality of Life*
  • Vision, Low / economics